Alfacell

Alfacell reports loss of $0.04 per share

Published in Medical Device Business Week, July 12th, 2006

Alfacell Corp. (ACEL), reported financial results and key company highlights from the third quarter of the company's fiscal year, which ended on April 30, 2006.

During the third quarter, Alfacell recorded a net loss of $1,638,000 or $0.04 per common share, as compared to a net loss of $1,675,000 or $0.05 per common share for the same period in FY 2005. The net loss for the third quarter includes a non-cash charge of $276,000 which reflects the accounting for share based payment as required by SFAS 123. The share-based compensation expense is expected to continue as a result of the adoption of SFAS 123, which requires the company to charge a non-cash compensation expense...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week

Source: Medical Device Business Week (2006-07-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry